Ventyx Biosciences
Stock Forecast, Prediction & Price Target
Ventyx Biosciences Financial Estimates
Ventyx Biosciences Revenue Estimates
Ventyx Biosciences EBITDA Estimates
Ventyx Biosciences Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $66.69M Low: $66.69M High: $66.69M avg. 0% | Avg: $182.01M Low: $182.01M High: $182.01M avg. 172.89% | Avg: $409.12M Low: $409.12M High: $409.12M avg. 124.77% |
Net Income
% change YoY
| $-78.36M N/A | $-107.95M -37.75% | $-192.96M -78.74% | Avg: $-182.88M Low: $-259.93M High: $-107.13M avg. 5.22% | Avg: $-150.4M Low: $-154.55M High: $44.49M avg. 17.76% | Avg: $-65.91M Low: $-65.91M High: $-65.91M avg. 56.17% | Avg: $33.22M Low: $33.22M High: $33.22M avg. 150.39% |
EBITDA
% change YoY
| $-72.59M N/A | $-108.42M -49.35% | $-207.99M -91.83% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$1.55 N/A | -$2.06 -32.90% | -$3.3 -60.19% | Avg: -$2.62 Low: -$4.44 High: -$1.83 avg. 20.56% | Avg: -$1.71 Low: -$2.64 High: $0.76 avg. 34.76% | Avg: -$1.13 Low: -$1.13 High: -$1.13 avg. 34.15% | Avg: $0.57 Low: $0.57 High: $0.57 avg. 150.39% |
Operating Expenses
% change YoY
| $67.14M N/A | $113.13M 68.49% | $207.99M 83.84% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Ventyx Biosciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 57.38% in 2025-2028.
We have gathered data from 7 analysts. Their low estimate is -259.93M, average is -182.88M and high is -107.13M.
What is Ventyx Biosciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 74.41% in 2025-2028.
We have gathered data from 7 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Ventyx Biosciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 59.97% in 2025-2028.
We have gathered data from 7 analysts. Their low earnings per share estimate is -$4.44, average is -$2.62 and high is $-1.83.
What is the best performing analyst?
In the last twelve months analysts have been covering Ventyx Biosciences stock. The most successful analyst is Jeff Jones.